970 related articles for article (PubMed ID: 15150094)
21. Roles of the RAF/MEK/ERK and PI3K/PTEN/AKT pathways in malignant transformation and drug resistance.
McCubrey JA; Steelman LS; Abrams SL; Lee JT; Chang F; Bertrand FE; Navolanic PM; Terrian DM; Franklin RA; D'Assoro AB; Salisbury JL; Mazzarino MC; Stivala F; Libra M
Adv Enzyme Regul; 2006; 46():249-79. PubMed ID: 16854453
[TBL] [Abstract][Full Text] [Related]
22. ERK signalling and oncogene transformation are not impaired in cells lacking A-Raf.
Mercer K; Chiloeches A; Hüser M; Kiernan M; Marais R; Pritchard C
Oncogene; 2002 Jan; 21(3):347-55. PubMed ID: 11821947
[TBL] [Abstract][Full Text] [Related]
23. C-Raf inhibits MAPK activation and transformation by B-Raf(V600E).
Karreth FA; DeNicola GM; Winter SP; Tuveson DA
Mol Cell; 2009 Nov; 36(3):477-86. PubMed ID: 19917255
[TBL] [Abstract][Full Text] [Related]
24. Activation of the RAF/mitogen-activated protein/extracellular signal-regulated kinase kinase/extracellular signal-regulated kinase pathway mediates apoptosis induced by chelerythrine in osteosarcoma.
Yang R; Piperdi S; Gorlick R
Clin Cancer Res; 2008 Oct; 14(20):6396-404. PubMed ID: 18927278
[TBL] [Abstract][Full Text] [Related]
25. The transcription factor NFAT1 induces apoptosis through cooperation with Ras/Raf/MEK/ERK pathway and upregulation of TNF-α expression.
Robbs BK; Lucena PI; Viola JP
Biochim Biophys Acta; 2013 Aug; 1833(8):2016-28. PubMed ID: 23583303
[TBL] [Abstract][Full Text] [Related]
26. Transformation potency of ErbB heterodimer signaling is determined by B-Raf kinase.
Hatakeyama M; Yumoto N; Yu X; Shirouzu M; Yokoyama S; Konagaya A
Oncogene; 2004 Jun; 23(29):5023-31. PubMed ID: 15064721
[TBL] [Abstract][Full Text] [Related]
27. Regulation and role of Raf-1/B-Raf heterodimerization.
Rushworth LK; Hindley AD; O'Neill E; Kolch W
Mol Cell Biol; 2006 Mar; 26(6):2262-72. PubMed ID: 16508002
[TBL] [Abstract][Full Text] [Related]
28. Human alphaA- and alphaB-crystallins prevent UVA-induced apoptosis through regulation of PKCalpha, RAF/MEK/ERK and AKT signaling pathways.
Liu JP; Schlosser R; Ma WY; Dong Z; Feng H; Liu L; Huang XQ; Liu Y; Li DW
Exp Eye Res; 2004 Sep; 79(3):393-403. PubMed ID: 15336502
[TBL] [Abstract][Full Text] [Related]
29. Mutations of C-RAF are rare in human cancer because C-RAF has a low basal kinase activity compared with B-RAF.
Emuss V; Garnett M; Mason C; Marais R
Cancer Res; 2005 Nov; 65(21):9719-26. PubMed ID: 16266992
[TBL] [Abstract][Full Text] [Related]
30. Oncogenic KRAS and BRAF activation of the MEK/ERK signaling pathway promotes expression of dual-specificity phosphatase 4 (DUSP4/MKP2) resulting in nuclear ERK1/2 inhibition.
Cagnol S; Rivard N
Oncogene; 2013 Jan; 32(5):564-76. PubMed ID: 22430215
[TBL] [Abstract][Full Text] [Related]
31. C-Raf is required for the initiation of lung cancer by K-Ras(G12D).
Karreth FA; Frese KK; DeNicola GM; Baccarini M; Tuveson DA
Cancer Discov; 2011 Jul; 1(2):128-36. PubMed ID: 22043453
[TBL] [Abstract][Full Text] [Related]
32. V599EB-RAF is an oncogene in melanocytes.
Wellbrock C; Ogilvie L; Hedley D; Karasarides M; Martin J; Niculescu-Duvaz D; Springer CJ; Marais R
Cancer Res; 2004 Apr; 64(7):2338-42. PubMed ID: 15059882
[TBL] [Abstract][Full Text] [Related]
33. SCH 51344 inhibits ras transformation by a novel mechanism.
Kumar CC; Prorock-Rogers C; Kelly J; Dong Z; Lin JJ; Armstrong L; Kung HF; Weber MJ; Afonso A
Cancer Res; 1995 Nov; 55(21):5106-17. PubMed ID: 7585559
[TBL] [Abstract][Full Text] [Related]
34. Raf-1 kinase activation is uncoupled from downstream MEK/ERK pathway in cells treated with Src tyrosine kinase inhibitor PP2.
Lee M
Biochem Biophys Res Commun; 2006 Nov; 350(2):450-6. PubMed ID: 17010316
[TBL] [Abstract][Full Text] [Related]
35. Protein kinase C alpha trigger Ras and Raf-independent MEK/ERK activation for TPA-induced growth inhibition of human hepatoma cell HepG2.
Wen-Sheng W
Cancer Lett; 2006 Jul; 239(1):27-35. PubMed ID: 16169661
[TBL] [Abstract][Full Text] [Related]
36. Elevated ERK-MAP kinase activity protects the FOS family member FRA-1 against proteasomal degradation in colon carcinoma cells.
Vial E; Marshall CJ
J Cell Sci; 2003 Dec; 116(Pt 24):4957-63. PubMed ID: 14625389
[TBL] [Abstract][Full Text] [Related]
37. Murine Ksr interacts with MEK and inhibits Ras-induced transformation.
Denouel-Galy A; Douville EM; Warne PH; Papin C; Laugier D; Calothy G; Downward J; Eychène A
Curr Biol; 1998 Jan; 8(1):46-55. PubMed ID: 9427625
[TBL] [Abstract][Full Text] [Related]
38. Hypoxic activation of nuclear factor-kappa B is mediated by a Ras and Raf signaling pathway and does not involve MAP kinase (ERK1 or ERK2).
Koong AC; Chen EY; Mivechi NF; Denko NC; Stambrook P; Giaccia AJ
Cancer Res; 1994 Oct; 54(20):5273-9. PubMed ID: 7923153
[TBL] [Abstract][Full Text] [Related]
39. Cellular functions of TC10, a Rho family GTPase: regulation of morphology, signal transduction and cell growth.
Murphy GA; Solski PA; Jillian SA; Pérez de la Ossa P; D'Eustachio P; Der CJ; Rush MG
Oncogene; 1999 Jul; 18(26):3831-45. PubMed ID: 10445846
[TBL] [Abstract][Full Text] [Related]
40. Transfection of constitutively active mitogen-activated protein/extracellular signal-regulated kinase kinase confers tumorigenic and metastatic potentials to NIH3T3 cells.
Welch DR; Sakamaki T; Pioquinto R; Leonard TO; Goldberg SF; Hon Q; Erikson RL; Rieber M; Rieber MS; Hicks DJ; Bonventre JV; Alessandrini A
Cancer Res; 2000 Mar; 60(6):1552-6. PubMed ID: 10749122
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
